0000932440-17-000088.txt : 20171129
0000932440-17-000088.hdr.sgml : 20171129
20171129170702
ACCESSION NUMBER: 0000932440-17-000088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171127
FILED AS OF DATE: 20171129
DATE AS OF CHANGE: 20171129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHREIBER ALAIN
CENTRAL INDEX KEY: 0001225149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 171229120
MAIL ADDRESS:
STREET 1: 2430 VANDERBILT BEACH ROAD
STREET 2: #108 - 190
CITY: NAPLES
STATE: FL
ZIP: 34109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ProQuest Associates IV LLC
CENTRAL INDEX KEY: 0001431819
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 171229122
BUSINESS ADDRESS:
STREET 1: 2430 VANDERBILT BEACH ROAD
STREET 2: #108 - 190
CITY: NAPLES
STATE: FL
ZIP: 34109
BUSINESS PHONE: 609-919-3567
MAIL ADDRESS:
STREET 1: 2430 VANDERBILT BEACH ROAD
STREET 2: #108 - 190
CITY: NAPLES
STATE: FL
ZIP: 34109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ProQuest Investments IV, L.P.
CENTRAL INDEX KEY: 0001431818
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 171229123
BUSINESS ADDRESS:
STREET 1: 2430 VANDERBILT BEACH ROAD
STREET 2: #108 - 190
CITY: NAPLES
STATE: FL
ZIP: 34109
BUSINESS PHONE: 609-919-3567
MAIL ADDRESS:
STREET 1: 2430 VANDERBILT BEACH ROAD
STREET 2: #108 - 190
CITY: NAPLES
STATE: FL
ZIP: 34109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moorin Jay
CENTRAL INDEX KEY: 0001033508
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 171229121
MAIL ADDRESS:
STREET 1: C/O PROQUEST INVESTMENTS, L.P
STREET 2: 2430 VANDERBILT BEACH ROAD, #108 - 190
CITY: NAPLES
STATE: FL
ZIP: 34109
FORMER NAME:
FORMER CONFORMED NAME: MOORIN JAY
DATE OF NAME CHANGE: 19970213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-11-27
1
0001668243
UroGen Pharma Ltd.
URGN
0001431818
ProQuest Investments IV, L.P.
2430 VANDERBILT BEACH ROAD, #108 - 190
NAPLES
FL
34109
0
0
1
0
0001431819
ProQuest Associates IV LLC
2430 VANDERBILT BEACH ROAD, #108 - 190
NAPLES
FL
34109
0
0
1
0
0001033508
Moorin Jay
C/O PROQUEST INVESTMENTS
2430 VANDERBILT BEACH ROAD, #108 - 190
NAPLES
FL
34109
0
0
1
0
0001225149
SCHREIBER ALAIN
C/O PROQUEST INVESTMENTS
2430 VANDERBILT BEACH ROAD, #108 - 190
NAPLES
FL
34109
0
0
1
0
Ordinary Shares, par value NIS 0.01 per share
2017-11-27
4
S
0
31491
41.12
D
1419838
D
Ordinary Shares, par value NIS 0.01 per share
2017-11-28
4
S
0
177807
40.51
D
1242031
D
The securities are directly held by ProQuest Investments IV, L.P. and indirectly held by ProQuest Associates IV, LLC, the General Partner of ProQuest Investments IV, L.P. The individual managing members of ProQuest Associates IV, LLC are Jay Moorin and Alain Schreiber, M.D., who may be deemed to have shared voting and investment and dispositive power with respect to these shares. Each individual managing member disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $41.00 to $41.68. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $40.50 to $41.01. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
/s/ Pasquale DeAngelis
2017-11-29